Cargando…
QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review
Chloroquine and hydroxychloroquine are now being widely used for treatment of COVID-19. Both medications prolong the QT interval and accordingly may put patients at increased risk for torsades de pointes and sudden death. Published guidance documents vary in their recommendations for monitoring and...
Autores principales: | Jankelson, Lior, Karam, Giorgio, Becker, Matthijs L., Chinitz, Larry A., Tsai, Meng-Chiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Heart Rhythm Society.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211688/ https://www.ncbi.nlm.nih.gov/pubmed/32438018 http://dx.doi.org/10.1016/j.hrthm.2020.05.008 |
Ejemplares similares
-
QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin
por: Chorin, Ehud, et al.
Publicado: (2020) -
Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine
por: Sarayani, Amir, et al.
Publicado: (2021) -
Chloroquine/erythromycin: QT interval prolongation and Torsade de Pointes: case report
Publicado: (2020) -
DOTHIEPIN, QT PROLONGATION AND TORSADES DE POINTES
por: Andrade, Chittaranjan, et al.
Publicado: (1999) -
QT Interval Prolongation as a Biomarker for Torsades de Pointes and Sudden Death in Drug Development
por: Sides, Gregory D.
Publicado: (2002)